Characteristic . | Total population (N = 12 062) . |
---|---|
Age, years (n = 12 062) | 67.0 ± 10.7 |
Sex, women (n = 12 062) | 7077 (58.7%) |
BMI, kg/m2 (n = 9829) | 27.2 ± 4.2 |
Smoking, n (valid %) (n = 10 052) | |
Never | 3293 (32.8%) |
Past | 4802 (47.8%) |
Current | 1957 (19.5%) |
Alcohol, g/day (n = 8272) | 5.7 (0.5–14.3) |
Serum cholesterol, mmol/L (n = 9871) | 5.7 ± 1.0 |
Serum triglyceride, mmol/L (n = 9902) | 1.5 ± 0.8 |
Systolic blood pressure, mmHg (n = 9927) | 140 ± 21 |
Diastolic blood pressure, mmHg (n = 9927) | 79 ± 12 |
Hypertension, n (valid %) (n = 9902) | 6250 (63.1%) |
Diabetes, n (valid %) (n = 10 337) | 1246 (12.1%) |
History of CVD, n (valid %) (n = 10 286) | 865 (8.4%) |
Use of antihypertensive medication (n = 9796) | 3267 (33.4%) |
Use of lipid-lowering medication (n = 10 920) | 1780 (16.3%) |
Use of cardiac medication (n = 10 920) | 895 (8.2%) |
Characteristic . | Total population (N = 12 062) . |
---|---|
Age, years (n = 12 062) | 67.0 ± 10.7 |
Sex, women (n = 12 062) | 7077 (58.7%) |
BMI, kg/m2 (n = 9829) | 27.2 ± 4.2 |
Smoking, n (valid %) (n = 10 052) | |
Never | 3293 (32.8%) |
Past | 4802 (47.8%) |
Current | 1957 (19.5%) |
Alcohol, g/day (n = 8272) | 5.7 (0.5–14.3) |
Serum cholesterol, mmol/L (n = 9871) | 5.7 ± 1.0 |
Serum triglyceride, mmol/L (n = 9902) | 1.5 ± 0.8 |
Systolic blood pressure, mmHg (n = 9927) | 140 ± 21 |
Diastolic blood pressure, mmHg (n = 9927) | 79 ± 12 |
Hypertension, n (valid %) (n = 9902) | 6250 (63.1%) |
Diabetes, n (valid %) (n = 10 337) | 1246 (12.1%) |
History of CVD, n (valid %) (n = 10 286) | 865 (8.4%) |
Use of antihypertensive medication (n = 9796) | 3267 (33.4%) |
Use of lipid-lowering medication (n = 10 920) | 1780 (16.3%) |
Use of cardiac medication (n = 10 920) | 895 (8.2%) |
Data are presented as number (%), mean ± SD or median (interquartile range). Values are given for non-imputed data. The n represents the number of participants without missing data. BMI, body mass index; CVD, cardiovascular disease; n, number.
Characteristic . | Total population (N = 12 062) . |
---|---|
Age, years (n = 12 062) | 67.0 ± 10.7 |
Sex, women (n = 12 062) | 7077 (58.7%) |
BMI, kg/m2 (n = 9829) | 27.2 ± 4.2 |
Smoking, n (valid %) (n = 10 052) | |
Never | 3293 (32.8%) |
Past | 4802 (47.8%) |
Current | 1957 (19.5%) |
Alcohol, g/day (n = 8272) | 5.7 (0.5–14.3) |
Serum cholesterol, mmol/L (n = 9871) | 5.7 ± 1.0 |
Serum triglyceride, mmol/L (n = 9902) | 1.5 ± 0.8 |
Systolic blood pressure, mmHg (n = 9927) | 140 ± 21 |
Diastolic blood pressure, mmHg (n = 9927) | 79 ± 12 |
Hypertension, n (valid %) (n = 9902) | 6250 (63.1%) |
Diabetes, n (valid %) (n = 10 337) | 1246 (12.1%) |
History of CVD, n (valid %) (n = 10 286) | 865 (8.4%) |
Use of antihypertensive medication (n = 9796) | 3267 (33.4%) |
Use of lipid-lowering medication (n = 10 920) | 1780 (16.3%) |
Use of cardiac medication (n = 10 920) | 895 (8.2%) |
Characteristic . | Total population (N = 12 062) . |
---|---|
Age, years (n = 12 062) | 67.0 ± 10.7 |
Sex, women (n = 12 062) | 7077 (58.7%) |
BMI, kg/m2 (n = 9829) | 27.2 ± 4.2 |
Smoking, n (valid %) (n = 10 052) | |
Never | 3293 (32.8%) |
Past | 4802 (47.8%) |
Current | 1957 (19.5%) |
Alcohol, g/day (n = 8272) | 5.7 (0.5–14.3) |
Serum cholesterol, mmol/L (n = 9871) | 5.7 ± 1.0 |
Serum triglyceride, mmol/L (n = 9902) | 1.5 ± 0.8 |
Systolic blood pressure, mmHg (n = 9927) | 140 ± 21 |
Diastolic blood pressure, mmHg (n = 9927) | 79 ± 12 |
Hypertension, n (valid %) (n = 9902) | 6250 (63.1%) |
Diabetes, n (valid %) (n = 10 337) | 1246 (12.1%) |
History of CVD, n (valid %) (n = 10 286) | 865 (8.4%) |
Use of antihypertensive medication (n = 9796) | 3267 (33.4%) |
Use of lipid-lowering medication (n = 10 920) | 1780 (16.3%) |
Use of cardiac medication (n = 10 920) | 895 (8.2%) |
Data are presented as number (%), mean ± SD or median (interquartile range). Values are given for non-imputed data. The n represents the number of participants without missing data. BMI, body mass index; CVD, cardiovascular disease; n, number.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.